CLOV vs INTC Stock Comparison
CLOV currently leads INTC in this stock comparison, with AIQ scores of 47 vs 30. The clearest difference is momentum.
What is the main difference between CLOV and INTC?
CLOV leads the current stock comparison as Clover Health Investments, Corp., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Clover Health Investments, Corp. vs Intel Corp.
CLOV leads
CLOV leads by 17 AIQ points, primarily on Momentum and Value, having only recently taken the lead back from INTC. Wall Street currently favors INTC on target upside.
Fragile: 3 of 6 evidence groups support CLOV, the lead recently changed hands, and its signal state is cleanly positive.
Clover Health Investments, Corp.
Intel Corp.
The Algovestiq AIQ Score currently favors CLOV over INTC, 47 versus 30 as of Oct 21, 2026. CLOV's advantage is driven primarily by stronger momentum and value. CLOV also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors INTC. 3 of 6 covered evidence groups favor CLOV today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. CLOV lead: Reversed — INTC led by 2 AIQ points 30 sessions ago; CLOV now leads by 17.
Compare Clover Health Investments, Corp. and Intel Corp. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare CLOV and INTC against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum74 vs 21CLOV +53
- Value42 vs 30CLOV +12
- Risk Resilience32 vs 29Even
- Quality38 vs 39Even
3 of 6 evidence groups favor CLOV. CLOV’s edge is concentrated in momentum and value.
What changed since the last close
Latest scored session 2026-10-20, compared against the prior scored session 2026-10-19.
Largest factor move: Momentum +22
New signals
- Uptrend Structure Active — bullish, trend, long horizon
- MACD Bullish Crossover — bullish, momentum, short horizon
No factor moved materially.
No signal started or stopped since the prior session; its 5 active signals are unchanged.
CLOV's lead widened by 5 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — CLOV and INTC both carry a full feed there.
The central trade-off
CLOV (Clover Health Investments, Corp.): the stronger current systematic profile, led by momentum and value.
INTC (Intel Corp.): the counter-case, on analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
CLOVCLOV on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
CLOVCLOV on combined revenue and EPS growth.
Value
CLOVCLOV on the peer-relative Value factor, by 12 points.
Momentum
CLOVCLOV on the Momentum factor, by 53 points.
Lower downside
INTCINTC carries the lower 1-month annualized volatility.
Analyst upside
INTCINTC on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors CLOV, analyst targets favor INTC. That disagreement is the most useful thing on this page.
| Measure | CLOV | INTC | Note |
|---|---|---|---|
| Implied upside to target | +6.5% | +18.2% | INTC has more room |
| Target dispersion | +35.4% | +122.9% | Lower is tighter analyst agreement |
| Consensus | Buy | Hold | Context, not a primary driver |
| Analysts covering | 3 | 27 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor CLOV. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | CLOV | 47 vs 30 |
| Fundamentals | Even | EPS growth -4.6% vs -195.9%; TTM ROE -5.4% vs -10.8%; gross margin 18.6% vs 38.9%; operating margin -0.7% vs 0.1% |
| Valuation | CLOV | Value 42 vs 30 |
| Technicals | CLOV | Price vs 50-day 7.2% vs -9.6%; vs 200-day 38.7% vs 7.8% |
| Risk Resilience | Even | Risk Resilience 32 vs 29 |
| Analyst expectations | INTC | Target upside 6.5% vs 18.2% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CLOV and INTC and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is wide at 17 points. (supports the conclusion holding)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The lead has swung materially session to session. (argues the conclusion is provisional)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CLOV.
How the comparison changed
120 daily snapshots · Jun 21 – Oct 20CLOV lead: Reversed — INTC led by 2 AIQ points 30 sessions ago; CLOV now leads by 17.
- Today
- CLOV +17
- 47 vs 30
- 7 sessions ago
- CLOV +16
- 46 vs 30
- 30 sessions ago
- INTC +2
- 41 vs 43
- 90 sessions ago
- INTC +1
- 41 vs 42
The lead changed hands 3 times in this window, most recently on Sep 10 when CLOV moved ahead of INTC.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 0 bearish / 1 neutral
Only CLOV
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
- MACD Bullish Crossover — bullish, momentum, short horizon
2 bullish / 2 bearish / 1 neutral, conflicted
Only INTC
- Keltner Channel Breakdown — bearish, volatility, short horizon
- RSI Oversold - Potential Bounce — bullish, momentum, short horizon
- MACD Bearish Crossover — bearish, momentum, short horizon
Both carry 2 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode.
INTC is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is down while the AIQ Score moved up 5 points over the same session — price and model disagree (price -0.42%, AIQ +5 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.39%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1INTC closes the Momentum gap — currently 53 points behind, the largest single contributor to CLOV's edge.
- 2INTC's Keltner Channel Breakdown resolves — a bearish volatility rule currently active against it.
- 3CLOV's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | CLOV | INTC |
|---|---|---|
| Revenue growth (YoY) | -0.8% | 18.8% |
| EPS growth (YoY) | -4.6% | -195.9% |
| Gross margin | 18.6% | 38.9% |
| Operating margin | -0.7% | 0.1% |
| Return on equity (TTM) | -5.4% | -10.8% |
| Debt to equity | 0 | 0.58 |
Performance
CLOV leads 4 of 6 windows| Metric | CLOV | INTC |
|---|---|---|
| 1 week (5 sessions) | -0.2% | -10.8% |
| 1 month (20 sessions) | 2.8% | -26% |
| 3 months (63 sessions) | 2.8% | -10.7% |
| 6 months (126 sessions) | 100.8% | 38.4% |
| Year to date | 104.3% | 148.5% |
| 1 year (252 sessions) | 77.8% | 148.9% |
Technicals
CLOV has the stronger structure| Metric | CLOV | INTC |
|---|---|---|
| RSI (14) | 64.8 | 16.4 |
| ADX (14) | 21.1 | 23.3 |
| Price vs 50-day | 7.2% | -9.6% |
| Price vs 200-day | 38.7% | 7.8% |
| Volatility (1M, annualized) | 51.1% | 46.6% |
Risk
Split| Metric | CLOV | INTC |
|---|---|---|
| Beta | 1.26 | 3.08 |
| Sharpe ratio | 1.13 | 1.5 |
| Sortino ratio | 2.15 | 2.73 |
| Max drawdown | -55.5% | -41.9% |
| Current drawdown | -11.3% | -34.9% |
| Annualized volatility | 66.2% | 77.8% |
| Value at risk (95%) | -4.8% | -6.2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, CLOV or INTC?
On the Algovestiq AIQ Score, CLOV is the stronger of the two as of Oct 21, 2026, scoring 47 against INTC's 30. The edge comes from momentum and value. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is CLOV or INTC the better buy right now?
CLOV carries the stronger systematic profile as of Oct 21, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.
Why does the AIQ Score favor CLOV over INTC?
The composite weights Quality, Value, Momentum and Risk Resilience. CLOV leads Momentum by 53 points; CLOV leads Value by 12 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, CLOV or INTC?
Analyst price targets imply +6.5% upside for CLOV and +18.2% for INTC, so the Street currently favors INTC. That points the opposite way to the AIQ Score, which favors CLOV. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, CLOV or INTC?
CLOV is the better-valued of the two on the peer-relative Value factor. CLOV on the peer-relative Value factor, by 12 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, CLOV or INTC?
CLOV on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, CLOV or INTC?
CLOV on the Momentum factor, by 53 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, CLOV or INTC?
INTC is the more resilient of the two, so the other name carries the higher downside risk. INTC carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is CLOV more profitable than INTC?
The profitability evidence is mixed: gross margin 18.6% vs 38.9%; operating margin -0.7% vs 0.1%; ttm roe -5.4% vs -10.8%. CLOV leads on one measure and INTC on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is CLOV's lead over INTC getting stronger or weaker?
CLOV lead: Reversed — INTC led by 2 AIQ points 30 sessions ago; CLOV now leads by 17. This is measured from 120 daily comparison snapshots between 2026-06-21 and 2026-10-20. The lead has changed hands 3 times in that window, most recently on 2026-09-10, when CLOV moved ahead of INTC.
What would change the CLOV vs INTC verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: INTC closes the Momentum gap — currently 53 points behind, the largest single contributor to CLOV's edge; INTC's Keltner Channel Breakdown resolves — a bearish volatility rule currently active against it; CLOV's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about CLOV and INTC?
CLOV: 4 bullish / 0 bearish / 1 neutral. INTC: 2 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CLOV is Golden Cross Active (bullish, long horizon). On INTC it is Golden Cross Active (bullish, long horizon).
Compare CLOV and INTC with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.